314 related articles for article (PubMed ID: 36651824)
21. Concentration-dependent protein adsorption at the nano-bio interfaces of polymeric nanoparticles and serum proteins.
Zhang TX; Zhu GY; Lu BY; Zhang CL; Peng Q
Nanomedicine (Lond); 2017 Nov; 12(22):2757-2769. PubMed ID: 29017387
[TBL] [Abstract][Full Text] [Related]
22. Protein corona: implications for nanoparticle interactions with pulmonary cells.
Konduru NV; Molina RM; Swami A; Damiani F; Pyrgiotakis G; Lin P; Andreozzi P; Donaghey TC; Demokritou P; Krol S; Kreyling W; Brain JD
Part Fibre Toxicol; 2017 Oct; 14(1):42. PubMed ID: 29084556
[TBL] [Abstract][Full Text] [Related]
23. The Surface Charge of Polymer-Coated Upconversion Nanoparticles Determines Protein Corona Properties and Cell Recognition in Serum Solutions.
Liang L; Everest-Dass AV; Kostyuk AB; Khabir Z; Zhang R; Trushina DB; Zvyagin AV
Cells; 2022 Nov; 11(22):. PubMed ID: 36429072
[TBL] [Abstract][Full Text] [Related]
24. Fluorescence correlation spectroscopy as a tool for the study of the intracellular dynamics and biological fate of protein corona.
Martinez-Moro M; Di Silvio D; Moya SE
Biophys Chem; 2019 Oct; 253():106218. PubMed ID: 31325709
[TBL] [Abstract][Full Text] [Related]
25. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
[TBL] [Abstract][Full Text] [Related]
26. Exploring the relationships between physiochemical properties of nanoparticles and cell damage to combat cancer growth using simple periodic table-based descriptors.
Roy J; Roy K
Beilstein J Nanotechnol; 2024; 15():297-309. PubMed ID: 38505811
[TBL] [Abstract][Full Text] [Related]
27. Predicting zeta potential of liposomes from their structure: A nano-QSPR model for DOPE, DC-Chol, DOTAP, and EPC formulations.
Jarzynska K; Gajewicz-Skretna A; Ciura K; Puzyn T
Comput Struct Biotechnol J; 2024 Dec; 25():3-8. PubMed ID: 38328349
[TBL] [Abstract][Full Text] [Related]
28. Research progress and application opportunities of nanoparticle-protein corona complexes.
Huang W; Xiao G; Zhang Y; Min W
Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
[TBL] [Abstract][Full Text] [Related]
29. Development of a fast and simple method for the isolation of superparamagnetic iron oxide nanoparticles protein corona from protein-rich matrices.
Soliman MG; Trinh DN; Ravagli C; Meleady P; Henry M; Movia D; Doumett S; Cappiello L; Prina-Mello A; Baldi G; Monopoli MP
J Colloid Interface Sci; 2024 Apr; 659():503-519. PubMed ID: 38184993
[TBL] [Abstract][Full Text] [Related]
30. Understanding the nanoparticle-protein corona complexes using computational and experimental methods.
Kharazian B; Hadipour NL; Ejtehadi MR
Int J Biochem Cell Biol; 2016 Jun; 75():162-74. PubMed ID: 26873405
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Competition at the Nano-Bio Interface Enables Comprehensive Characterization of Protein Corona Dynamics and Deep Coverage of Proteomes.
Ferdosi S; Stukalov A; Hasan M; Tangeysh B; Brown TR; Wang T; Elgierari EM; Zhao X; Huang Y; Alavi A; Lee-McMullen B; Chu J; Figa M; Tao W; Wang J; Goldberg M; O'Brien ES; Xia H; Stolarczyk C; Weissleder R; Farias V; Batzoglou S; Siddiqui A; Farokhzad OC; Hornburg D
Adv Mater; 2022 Nov; 34(44):e2206008. PubMed ID: 35986672
[TBL] [Abstract][Full Text] [Related]
32. Development of a novel in silico model of zeta potential for metal oxide nanoparticles: a nano-QSPR approach.
Wyrzykowska E; Mikolajczyk A; Sikorska C; Puzyn T
Nanotechnology; 2016 Nov; 27(44):445702. PubMed ID: 27668939
[TBL] [Abstract][Full Text] [Related]
33. Revising Protein Corona Characterization and Combining ITC and Nano-DSC to Understand the Interaction of Proteins With Porous Nanoparticles.
Balmori A; Sandu R; Gheorghe D; Botea-Petcu A; Precupas A; Tanasescu S; Sánchez-García D; Borrós S
Front Bioeng Biotechnol; 2021; 9():650281. PubMed ID: 34708023
[TBL] [Abstract][Full Text] [Related]
34. In situ analysis of nanoparticle soft corona and dynamic evolution.
Baimanov D; Wang J; Zhang J; Liu K; Cong Y; Shi X; Zhang X; Li Y; Li X; Qiao R; Zhao Y; Zhou Y; Wang L; Chen C
Nat Commun; 2022 Sep; 13(1):5389. PubMed ID: 36104325
[TBL] [Abstract][Full Text] [Related]
35. Analysis of temporally evolved nanoparticle-protein corona highlighted the potential ability of gold nanoparticles to stably interact with proteins and influence the major biochemical pathways in Brassica juncea.
Prakash S; Deswal R
Plant Physiol Biochem; 2020 Jan; 146():143-156. PubMed ID: 31751914
[TBL] [Abstract][Full Text] [Related]
36. Protein-Nanoparticle Interaction: Corona Formation and Conformational Changes in Proteins on Nanoparticles.
Park SJ
Int J Nanomedicine; 2020; 15():5783-5802. PubMed ID: 32821101
[TBL] [Abstract][Full Text] [Related]
37. Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.
García Vence M; Chantada-Vázquez MDP; Vázquez-Estévez S; Manuel Cameselle-Teijeiro J; Bravo SB; Núñez C
Clin Chim Acta; 2020 Feb; 501():102-111. PubMed ID: 31678275
[TBL] [Abstract][Full Text] [Related]
38. The protein corona and its effects on nanoparticle-based drug delivery systems.
Li H; Wang Y; Tang Q; Yin D; Tang C; He E; Zou L; Peng Q
Acta Biomater; 2021 Jul; 129():57-72. PubMed ID: 34048973
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticles-cell association predicted by protein corona fingerprints.
Palchetti S; Digiacomo L; Pozzi D; Peruzzi G; Micarelli E; Mahmoudi M; Caracciolo G
Nanoscale; 2016 Jul; 8(25):12755-63. PubMed ID: 27279572
[TBL] [Abstract][Full Text] [Related]
40. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
